DUARTE, Calif. —
City of Hope has been notified of the renewal of the prestigious comprehensive cancer center designation from the National Cancer Institute (NCI), a milestone that marks the institution’s 30th year with an NCI designation.
The recognition is the highest level granted by the NCI, part of the National Institutes of Health, awarded only to those institutions with world-class, state-of-the-art programs in multidisciplinary cancer research.
“We’re extremely pleased the NCI has once again recognized City of Hope’s outstanding achievements in scientific research, leading-edge treatments and patient care,” said Michael A. Friedman, M.D., City of Hope’s chief executive officer and Irell & Manella Cancer Center Director's Distinguished Chair. “Our innovations have helped scores of millions of people around the world and in our own community, and our patient care has become a model for institutions everywhere. We’re extremely proud not only to receive this prestigious honor, but to continue shaping the future of health.”
Institutions must meet rigorous standards to receive the designation, which accompanies increased federal funding, information sharing and resources. Such funding, and the corresponding designation, is especially notable considering the increasingly competitive NCI fiscal environment.
To meet the standards, institutions must show depth and breadth of research in laboratory, clinical and population-based research, as well as research that bridges these scientific areas. They must also demonstrate professional and public education efforts, including the sharing of health advances in their communities.
In announcing the approval, the NCI commended City of Hope in a variety of areas. It noted that:
Many programs have new leadership, which has infused new vision and new capabilities into the scientific programs.
Every program has examples of outstanding, even exceptional, science.
The leadership of the individual programs is outstanding both scientifically and administratively.
The cancer center has shown substantial growth of both new laboratory space and clinical space.
The institution maintains unique and differentiating core resources, such as the biological and chemical GMP facilities.
The center possesses all the scientific resources and intellectual capacity to succeed.
“Membership in the community of NCI-designated cancer centers confers a seat at the table where the strategic plans and initiatives of NCI are formed, and allows the center to represent the needs of its local community in national dialogue,” says the NCI in a description of the designation. “This access also creates opportunities for extensive information sharing and broader scientific collaborations with other NCI centers.”
The designation will benefit not only City of Hope, but also the surrounding communities. The accompanying grant, for which an amount has not yet been announced, will help ensure ongoing education and outreach efforts, as well as the dissemination of evidence-based findings and breakthrough discoveries.
About City of Hope
City of Hope is a leading research and treatment center for cancer, diabetes and other life-threatening diseases. Designated as a comprehensive cancer center, the highest recognition bestowed by the National Cancer Institute, City of Hope is also a founding member of the National Comprehensive Cancer Network, with research and treatment protocols that advance care throughout the nation. City of Hope’s main hospital is located in Duarte, Calif., just northeast of Los Angeles, with clinics in Antelope Valley and South Pasadena. It is ranked as one of "America's Best Hospitals" in cancer by U.S.News & World Report. Founded in 1913, City of Hope is a pioneer in the fields of bone marrow transplantation and genetics. For more information, visit www.cityofhope.org or follow City of Hope on
, Breakthroughs Blog or